Cargando…

Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer

Four different genes were identified by immunoscreening of a cDNA expression library from the human prostate cancer cell line DU145 with allogeneic sera from four prostate cancer patients. A cDNA encoding the nucleolar protein No55 was further analysed and shown to be expressed at the mRNA level in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fosså, A, Siebert, R, Aasheim, H-C, Mælandsmo, G M, Berner, A, Fosså, S D, Paus, E, Smeland, E B, Gaudernack, G
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363543/ https://www.ncbi.nlm.nih.gov/pubmed/10952778 http://dx.doi.org/10.1054/bjoc.2000.1365

Ejemplares similares

The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancer.
por: Fosså, S. D., et al.
Publicado: (1992)

Neuron-specific enolase--a serum tumour marker in seminoma?
por: Fosså, S. D., et al.
Publicado: (1992)

CD55 is over-expressed in the tumour environment
por: Li, L, et al.
Publicado: (2001)

Prostatic carcinoma: a multivariate analysis of prognostic factors.
por: Berner, A., et al.
Publicado: (1994)

Fertility in Norwegian testicular cancer patients
por: Fosså, S D, et al.
Publicado: (2000)

Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence
por: Hernes, E, et al.
Publicado: (2004)

Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens.
por: Berner, A., et al.
Publicado: (1993)

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours
por: Fosså, S D, et al.
Publicado: (1999)

89Strontium in bone metastases from hormone resistant prostate cancer: palliation effect and biochemical changes.
por: Fosså, S. D., et al.
Publicado: (1992)

Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II study.
por: Hernes, E. H., et al.
Publicado: (1997)

Integrated analysis of the prostate cancer small‐nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression
por: Crea, Francesco, et al.
Publicado: (2015)

Nucleolar damage correlates with neurotoxicity induced by different platinum drugs
por: McKeage, M J, et al.
Publicado: (2001)

Description and partial characterization of a nucleolar RNA-associated autoantigen defined by a human monoclonal antibody
Publicado: (1987)

Selection of tumour cell subpopulations occurs during cultivation of human tumours in soft agar. A DNA flow cytometric study.
por: Tveit, K. M., et al.
Publicado: (1985)

Circulating tumor cells in patients with metastatic castration resistant prostate cancer: exploratory findings at a tertiary referral hospital
por: Fosså, Sophie D, et al.
Publicado: (2014)

Salvage treatment in male patients with germ cell tumours.
por: Josefsen, D., et al.
Publicado: (1993)

Late-effect awareness and follow-up of cancer in general practice
por: Eikeland, Siri A., et al.
Publicado: (2022)

Identification of T-cell specific autoantigens
por: Hamann, D, et al.
Publicado: (2002)

Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection
por: Jacobsen, K D, et al.
Publicado: (1999)

Identification of Novel Native Autoantigens in Rheumatoid Arthritis
por: Poulsen, Thomas B. G., et al.
Publicado: (2020)

Why do patients with radiation-induced sarcomas have a poor sarcoma-related survival?
por: Bjerkehagen, B, et al.
Publicado: (2012)

Increased mortality rates in young and middle-aged patients with malignant germ cell tumours
por: Fosså, S D, et al.
Publicado: (2004)

Development of PBC/SSc overlap syndrome in chronic GVHD patient: immunological implications in the presence of mitochondrial, nucleolar and spindle midzone autoantigens
por: Assandri, Roberto, et al.
Publicado: (2017)

Nucleolar protein nucleolin functions in replication stress–induced DNA damage responses
por: Kawamura, Kasumi, et al.
Publicado: (2019)

Post-treatment parenthood in Hodgkin's lymphoma survivors
por: Kiserud, C E, et al.
Publicado: (2007)

A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma
por: Horwich, A, et al.
Publicado: (2000)

Treatment and outcome of patients with extragonadal germ cell tumours--the Norwegian Radium Hospital's experience 1979-94.
por: Dueland, S., et al.
Publicado: (1998)

Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system
por: Culig, Z, et al.
Publicado: (1999)

High Neuroticism Is Related to More Overall Functional Problems and Lower Function Scores in Men Who Had Surgery for Non-Relapsing Prostate Cancer
por: Dahl, Alv A., et al.
Publicado: (2022)

Renal function related to different treatment modalities for malignant germ cell tumours.
por: Aass, N., et al.
Publicado: (1990)

Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray
por: Bull, J H, et al.
Publicado: (2001)

The nucleolar protein SAHY1 is involved in pre-rRNA processing and normal plant growth
por: Hsu, Pei-jung, et al.
Publicado: (2020)

Immunogenicity of autoantigens
por: Backes, Christina, et al.
Publicado: (2011)

Prostate tumours from an Asian population: examination of bax, bcl-2, p53 and ras and identification of bax as prognostic marker
por: Chia, S-J, et al.
Publicado: (2000)

Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy
por: Kiserud, C E, et al.
Publicado: (2009)

Expression and regulation of prostate androgen regulated transcript-1 (PART-1) and identification of differential expression in prostatic cancer
por: Sidiropoulos, M, et al.
Publicado: (2001)

Risk factors for testicular germ cell tumours by histological tumour type
por: Coupland, C A C, et al.
Publicado: (1999)

Identification of kinectin as a novel Behçet's disease autoantigen
por: Lu, Yu, et al.
Publicado: (2005)

Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response
por: Cameron, D A, et al.
Publicado: (2000)

Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues
por: Schaik, R H N van, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_fdaird97g2eokvi3ukcehk2dqo